SAFETY AND EFFICACY OF INTRAVENTRICULAR 131I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 IN PATIENTS WITH CNS/LM DISEASE

被引:0
|
作者
Kramer, Kim [1 ]
Kushner, Brian [1 ]
Modak, Shakeel [1 ]
Pandit-Taskar, Neeta [1 ]
Tomlinson, Ursula [1 ]
Donzelli, Maria [1 ]
Wolden, Suzanne [1 ]
Zanzonico, Pat [1 ]
Humm, John [1 ]
Haque, Sophia [1 ]
Souweidane, Mark [1 ,2 ]
Greenfield, Jeffrey [3 ]
Basu, Ellen [1 ]
Roberts, Stephen [1 ]
Carrasquillo, Jorge [1 ]
Lewis, Jason [1 ]
Lyashchenko, Serge [1 ]
Larson, Steven [1 ]
Cheung, Nai-Kong [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Med Coll, New York, NY USA
[3] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PDCT-04
引用
收藏
页码:184 / 184
页数:1
相关论文
共 11 条
  • [1] SAFETY AND EFFICACY OF INTRAVENTRICULAR 131I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 IN PATIENTS WITH CNS/LM DISEASE
    Kramer, Kim
    Kushner, Brian
    Modak, Shakeel
    Pandit-Taskar, Neeta
    Tomlinson, Ursula
    Donzelli, Maria
    Wolden, Suzanne
    Zanzonico, Pat
    Humm, John
    Haque, Sophia
    Souweidane, Mark
    Greenfield, Jeffrey
    Basu, Ellen
    Roberts, Stephen
    Carrasquillo, Jorge
    Lewis, Jason
    Lyashchenko, Serge
    Larson, Steven
    Cheung, Nai-Kong
    NEURO-ONCOLOGY, 2017, 19 : 272 - 272
  • [2] Safety and Efficacy of Intraventricular 131I-Labeled Monoclonal Antibody 8H9 Targeting the Surface Glycoprotein B7-H3
    Kramer, K.
    Pandit-Taskar, N.
    Donzelli, M.
    Suzanne, W.
    Zanzonico, P.
    Humm, J.
    Haque, S.
    Souweidane, M.
    Greenfield, J.
    Carrasquillo, J.
    Lewis, J.
    Lyashchenko, S.
    Larson, S.
    Cheung, N. K.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S431 - S431
  • [3] SAFETY AND EFFICACY OF INTRAVENTRICULAR 131I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3
    Kramer, Kim
    Kushner, Brian
    Modak, Shakeel
    Taskar, Neeta Pandit
    Tomlinson, Ursula
    Donzelli, Maria
    Wolden, Suzanne
    Zanzonico, Pat
    Humm, John
    Haque, Sofia
    Souweidane, Mark
    Greenfield, Jeffrey
    Basu, Ellen
    Roberts, Stephen
    Carrasquillo, Jorge
    Lewis, Jason
    Lyashckenko, Serge
    Larson, Steven
    Cheung, Nai-Kong
    NEURO-ONCOLOGY, 2018, 20 : 99 - 99
  • [4] Intraventricular 131I-Labeled Monoclonal Antibody 8H9 (Omburtomab) Targeting the Surface Glycoprotein B7-H3 in Patients with CNS Malignancies
    Kramer, K.
    Kushner, B.
    Modak, S.
    Pandit-Taskar, N.
    Tomlinson, U.
    Donzelli, M.
    Wolden, S.
    Zanzonico, P.
    Humm, J.
    Haque, S.
    Souweidane, M.
    Greenfield, J.
    Basu, E.
    Roberts, S.
    Carrasquillo, J.
    Lewis, J.
    Lyashchenko, S.
    Larson, S.
    Cheung, N. K.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S439 - S439
  • [5] Therapy to target renal cell carcinoma using 131I-labeled B7-H3 monoclonal antibody
    Wang, Gongcheng
    Wu, Ziyu
    Wang, Yunyan
    Li, Xueqin
    Zhang, Guangbo
    Hou, Jianquan
    ONCOTARGET, 2016, 7 (17) : 24888 - 24898
  • [6] Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3
    Ahmed, Mahiuddin
    Cheng, Ming
    Zhao, Qi
    Goldgur, Yehuda
    Cheal, Sarah M.
    Guo, Hong-Fen
    Larson, Steven M.
    Cheung, Nai-Kong V.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (50) : 30018 - 30029
  • [7] Safety and efficacy of B7-H3 targeting CAR-T cell therapy for patients with recurrent GBM
    Zhang, Yang
    Feng, Rui
    Chi, Xiaohan
    Xian, Na
    Chen, Xianzhen
    Huang, Na
    Zhang, Yu
    Zhang, Kangna
    Zhang, Jindong
    Chen, Lieping
    Ji, Nan
    Huang, Gangxiong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] PHASE 1 STUDY OF INTRAVENTRICULAR 131I-OMBURTAMAB TARGETING B7H3 (CD276)-EXPRESSING CNS MALIGNANCIES
    Modak, Shakeel
    Pandit Taskar, Neeta
    Kushner, Brian
    Zanzonico, Pat
    Humm, John
    Donzelli, Maria
    Lewis, Jason
    Lyashchenko, Serge
    Chu, Bae
    Larson, Stephen
    Cheung, Nai Kong
    Kramer, Kim
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [9] Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Kim Kramer
    Neeta Pandit-Taskar
    Brian H. Kushner
    Pat Zanzonico
    John L. Humm
    Ursula Tomlinson
    Maria Donzelli
    Suzanne L. Wolden
    Sophia Haque
    Ira Dunkel
    Mark M. Souweidane
    Jeffrey P. Greenfield
    Satish Tickoo
    Jason S. Lewis
    Serge K. Lyashchenko
    Jorge A. Carrasquillo
    Bae Chu
    Christopher Horan
    Steven M. Larson
    Nai-Kong V. Cheung
    Shakeel Modak
    Journal of Hematology & Oncology, 15
  • [10] Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Kramer, Kim
    Pandit-Taskar, Neeta
    Kushner, Brian H.
    Zanzonico, Pat
    Humm, John L.
    Tomlinson, Ursula
    Donzelli, Maria
    Wolden, Suzanne L.
    Haque, Sophia
    Dunkel, Ira
    Souweidane, Mark M.
    Greenfield, Jeffrey P.
    Tickoo, Satish
    Lewis, Jason S.
    Lyashchenko, Serge K.
    Carrasquillo, Jorge A.
    Chu, Bae
    Horan, Christopher
    Larson, Steven M.
    Cheung, Nai-Kong V.
    Modak, Shakeel
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)